• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 144-158 of 247 results

1018 Exhibit: Enzinger et al, Phase II clinical trial of 13 cis retinoic acid and interfer...

Document IPR2018-01714, No. 1018 Exhibit - Enzinger et al, Phase II clinical trial of 13 cis retinoic acid and interferon ¿¿ 2a in patients with advanced esophageal carcinoma, Cancer, 851213 1217 1999 (P....

cite Cite Document

1049 Exhibit: Bell et al, Chapter 5 The Hematopoietic System and Development of B...

Document IPR2018-01714, No. 1049 Exhibit - Bell et al, Chapter 5 The Hematopoietic System and Development of Blood Cells, The Johns Hopkins Atlas of Human Functional Anatomy, 4th ed 1997 (P.T.A.B...

cite Cite Document

1012 Exhibit: Celgene Corp, Press Release, May 8, 2001

Document IPR2018-01714, No. 1012 Exhibit - Celgene Corp, Press Release, May 8, 2001 (P.T.A.B. Sep. 12, 2018)

cite Cite Document

1001 Exhibit: US Patent No 7,968,569 the 569 patent

Document IPR2018-01714, No. 1001 Exhibit - US Patent No 7,968,569 the 569 patent (P.T.A.B. Sep. 12, 2018)

cite Cite Document

1047 Exhibit: Palmer et al, Dose Intensity Analysis of Melphalan and Prednisone in...

Document IPR2018-01714, No. 1047 Exhibit - Palmer et al, Dose Intensity Analysis of Melphalan and Prednisone in Multiple Myeloma J Natl Cancer Inst, 80414 418 1988 (P.T.A.B. Sep. 12, 2018)

cite Cite Document

1025 Exhibit: Imashuku et al, Management of severe neutropenia with cyclosporin ...

Document IPR2018-01714, No. 1025 Exhibit - Imashuku et al, Management of severe neutropenia with cyclosporin during initial treatment of Epstein Barr virus related hemophagocytic lymphohistiocytosis,...

cite Cite Document

2016 Exhibit: Ex 2016 Lokhorst et al 1992

Document IPR2018-01714, No. 2016 Exhibit - Ex 2016 Lokhorst et al 1992 (P.T.A.B. Dec. 18, 2018)

cite Cite Document

1043 Exhibit: Palumbo, A, et al, Lenalidomide A new therapy for multiple myeloma,...

Document IPR2018-01714, No. 1043 Exhibit - Palumbo, A, et al, Lenalidomide A new therapy for multiple myeloma, Cancer Treatment Reviews 34283 291 2008 (P.T.A.B. Sep. 12, 2018)

cite Cite Document

2017 Exhibit: Ex 2017 Troussard

Document IPR2018-01714, No. 2017 Exhibit - Ex 2017 Troussard (P.T.A.B. Dec. 18, 2018)

cite Cite Document

2019 Exhibit: Ex 2019 Goudarzipour et al 2013

Document IPR2018-01714, No. 2019 Exhibit - Ex 2019 Goudarzipour et al 2013 (P.T.A.B. Dec. 18, 2018)

cite Cite Document

2014 Exhibit: Ex 2014 Barlogie 1991

Document IPR2018-01714, No. 2014 Exhibit - Ex 2014 Barlogie 1991 (P.T.A.B. Dec. 18, 2018)

cite Cite Document

2003 Exhibit: Ex 2003 Hatch Act

Document IPR2018-01714, No. 2003 Exhibit - Ex 2003 Hatch Act (P.T.A.B. Dec. 18, 2018)

cite Cite Document

1045 Exhibit: Gandhi, AK, Dexamethasone Synergizes with Lenalidomide to Inhibit...

Document IPR2018-01714, No. 1045 Exhibit - Gandhi, AK, Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide Induced Immunomodulation...

cite Cite Document

1017 Exhibit: V T DeVita, Jr, Chapter 16 Principles of Chemotherapy, Cancer Princ...

Document IPR2018-01714, No. 1017 Exhibit - V T DeVita, Jr, Chapter 16 Principles of Chemotherapy, Cancer Principles and Practice of Oncology, Fourth Edition 1993 (P.T.A.B. Sep. 12, 2018)

cite Cite Document

1051 Exhibit: US Food and Drug Administration, List of Orphan Designations and A...

Document IPR2018-01714, No. 1051 Exhibit - US Food and Drug Administration, List of Orphan Designations and Approvals, available at httpswwwaccessdatafdagovscriptsopdlistingoopd published online...

cite Cite Document
<< 1 2 3 4 5 ... 10 11 12 13 14 15 16 17 >>